C27H31F2N9O2 — CID 135355812
5-tert-butyl-N-[(5R)-2-(2,2-difluoroethyl)-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide (PubChem CID 135355812) has the molecular formula C27H31F2N9O2 and a molecular weight of 551.60 g/mol. Its IUPAC name is 5-tert-butyl-N-[(5R)-2-(2,2-difluoroethyl)-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide.
| Compound Name | 5-tert-butyl-N-[(5R)-2-(2,2-difluoroethyl)-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide |
|---|---|
| PubChem CID | 135355812 |
| Molecular Formula | C27H31F2N9O2 |
| Molecular Weight | 551.60 g/mol |
| Exact Mass | 551.26 |
| IUPAC Name | 5-tert-butyl-N-[(5R)-2-(2,2-difluoroethyl)-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,3,4-oxadiazole-2-carboxamide |
| SMILES | Cn1cc(Nc2nccc(-c3ccc4c(c3)CN(CC(F)F)CC[C@H]4NC(=O)c3nnc(C(C)(C)C)o3)n2)cn1 |
| InChI | InChI=1S/C27H31F2N9O2/c1-27(2,3)25-36-35-24(40-25)23(39)33-21-8-10-38(15-22(28)29)13-17-11-16(5-6-19(17)21)20-7-9-30-26(34-20)32-18-12-31-37(4)14-18/h5-7,9,11-12,14,21-22H,8,10,13,15H2,1-4H3,(H,33,39)(H,30,32,34)/t21-/m1/s1 |
| InChIKey | NYXRRLSENXQLCI-OAQYLSRUSA-N |
| XLogP | 4.24 |
| TPSA | 126.89 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 40 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 551.60 |
| LogP ≤ 5 | 4.24 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |